Gladstone Institutional Advisory LLC Amgen Inc Transaction History

Gladstone Institutional Advisory LLC

$1.81 Billion
Q1 2024

A detailed history of Gladstone Institutional Advisory LLC transactions in Amgen Inc stock. As of the latest transaction made, Gladstone Institutional Advisory LLC holds 4,916 shares of AMGN stock, worth $1.52 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

4,916

Previous 8,300 40.77%

Holding current value

$1.52 Million

Previous $2.39 Million 41.55%

% of portfolio

0.08%

Previous 0.13%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $909,856 - $1.1 Million	-3,384 Reduced 40.77%	4,916 $1.4 Million
Q4 2023 Feb 09, 2024	BUY	$255.7 - $288.46 $114,809 - $129,518	449 Added 5.72%	8,300 $2.39 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $66,032 - $81,980	-302 Reduced 3.7%	7,851 $2.11 Million
Q2 2023 Aug 10, 2023	SELL	$214.27 - $253.37 $500,106 - $591,365	-2,334 Reduced 22.26%	8,153 $1.81 Million
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $76,542 - $93,292	-339 Reduced 3.13%	10,487 $2.54 Million

Q4 2022 Feb 01, 2023	BUY	$229.03 - $291.01 $1.32 Million - $1.68 Million	5,767 Added 113.99%	10,826 $2.84 Million
Q3 2022 Jan 27, 2023	SELL	$224.46 - $253.15 $61,053 - $68,856	-272 Reduced 5.1%	5,059 $1.14 Million
Q3 2022 Oct 20, 2022	SELL	$224.46 - $253.15 $61,053 - $68,856	-272 Reduced 5.1%	5,059 $1.14 Million
Q2 2022 Jan 27, 2023	SELL	$230.71 - $256.74 $478,492 - $532,478	-2,074 Reduced 28.01%	5,331 $1.3 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $478,492 - $532,478	-2,074 Reduced 28.01%	5,331 $1.3 Million
Q1 2022 Jan 27, 2023	SELL	$219.27 - $242.57 $314,433 - $347,845	-1,434 Reduced 16.22%	7,405 $1.79 Million
Q1 2022 May 04, 2022	SELL	$219.27 - $242.57 $314,433 - $347,845	-1,434 Reduced 16.22%	7,405 $1.79 Million
Q4 2021 Jan 27, 2023	BUY	$198.88 - $227.6 $208,227 - $238,297	1,047 Added 13.44%	8,839 $1.99 Million
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $208,227 - $238,297	1,047 Added 13.44%	8,839 $1.99 Million
Q3 2021 Jan 27, 2023	BUY	$212.27 - $248.7 $341,330 - $399,909	1,608 Added 26.0%	7,792 $1.66 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $341,330 - $399,909	1,608 Added 26.0%	7,792 $1.66 Million
Q2 2021 Jan 27, 2023	BUY	$233.58 - $259.14 $584,650 - $648,627	2,503 Added 68.0%	6,184 $1.51 Million
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $584,650 - $648,627	2,503 Added 68.0%	6,184 $1.51 Million
Q1 2021 Jan 27, 2023	BUY	$221.91 - $258.6 $526,370 - $613,399	2,372 Added 181.21%	3,681 $916,000
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $526,370 - $613,399	2,372 Added 181.21%	3,681 $916,000
Q4 2020 Jan 27, 2023	SELL	$216.38 - $257.67 $22,719 - $27,055	-105 Reduced 7.43%	1,309 $301,000
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $22,719 - $27,055	-105 Reduced 7.43%	1,309 $301,000
Q3 2020 Jan 27, 2023	SELL	$234.65 - $260.95 $855,299 - $951,162	-3,645 Reduced 72.05%	1,414 $359,000
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $42,940 - $47,753	183 Added 14.87%	1,414 $359,000
Q2 2020 Aug 17, 2020	SELL	$197.81 - $242.74 $62,507 - $76,705	-316 Reduced 20.43%	1,231 $290,000
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $34,990 - $46,406	-192 Reduced 11.04%	1,547 $314,000
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $20,813 - $26,752	-110 Reduced 5.95%	1,739 $419,000
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $45,094 - $54,032	-259 Reduced 12.29%	1,849 $358,000
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $106,187 - $124,476	637 Added 43.3%	2,108 $389,000
Q1 2019 May 10, 2019	SELL	$180.87 - $203.88 $28,577 - $32,213	-158 Reduced 9.7%	1,471 $279,000
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $290,613 - $339,239	1,629 New	1,629 $317,000

Others Institutions Holding AMGN

# of Institutions

2,933

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $165B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gladstone Institutional Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gladstone Institutional Advisory LLC with notifications on news.

Account

Gladstone Institutional Advisory LLC Amgen Inc Transaction History